GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...

This is a retrospective cohort study of 44 eyes of 33 patients. The eyes all had corneal astigmatism of 1 to 5 D, and between July 2006 and March 2007 received an AcrySof toric intraocular lens during ...

Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...

The FINANCIAL — Basel, June 18, 2018 Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the ...

The analyses above provided the opportunity to predict the performance of the AcrySof ® Toric ® intraocular lens in simulated 'real-world' conditions, where surgical variables were allowed to vary and ...

The FINANCIAL — Alcon, one of the global leaders in eye care and a division of Novartis, has received US Food and Drug Administration (FDA) approval for its AcrySof IQ Aspheric IOL with the ...

Disclaimer: This is sponsored content paid for by Vision for Life. All opinions and views are of the advertiser and does not reflect the same of NewsChannel 5 Nashville. In today’s Your Health Matters ...

Please provide your email address to receive an email when new articles are posted on . Part one of this series focused on balancing the three interrelated concepts of presbyopia-correcting or visual ...

FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...

Data on Alcon’s products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained ...